Lec 2 treatment of TB and covid: Flashcards
Clinical presentation of TB in NON HIV infected patient:
malasie
anorexia and wieght loss
cough
fever
night sweats
First line tuberculosis treatment:
Ethambutol
Isoniazid
rifampin
pyrazinimamide
two treatments of LTBI that resolves in 3 months:
Isoniazid and Rifampin daily
Isoniazid and rifapentine weekly
CDC recommended.
treatment that resolves in 4 months:
daily rifampin
Active form of TB treatment and how long it takes and what can be added to it:
9 months of isoniazid and rifampin
can add pyrazinamide AND ethambutol for the first 2 months—— treatment reduced to 6 months.
Streptomycin, kanamycin,amikacin
(aminoglycosides) used for:
Multidrug resistant TB
Capreomycin used for
multidrug resistant TB
Levofloxacin,moxifloxacin
(fluoroquinilones) used for:
Multi drug resistant TB
Any first line active drugs++ Cycloserine,ethionamide,p-aminosalicyclic acid treat what
MDR
Clofazimine and linezolid
for extensive drug resistance TB
(XDR TB)
Bedaquiline, pretomanid and linezolid is for:
most promising shorter regimens for MDR TB.
6 months
Initial treatment for pregnant female with TB:
Isoniazid, Rifampin and ethambutol for 9 months
vitamin B6 is given to patient with risk of neuropathy, and these patients are:
-pregnant
-breastfeeding infants
-person with HIV
-diabetes,chronic renal failure,alcoholism
-extreme ages
Adverse reactions of Isoniazid:
Allergic reactions: fever, skin rash, Drug induced SLE
Direct toxicity:
-INH-induced hepatitis (most common)
-CNS toxicity
-periphral neuropathy (B6)
Rifa and its derivatives:
first line oral agents
```
Can be used as an alternative to isoniazid:
Rifampin
Adverse reactions of rifampin:
-harmless orange color to bodily secretions
-rashes, thrombocytopenia, nephritis
-jaundice and hepatitis
mycobacterial Arabinosyl transferase inhibitor:
Ethambutol
most mild COVID is managed with:
acetaminophen and ibuprofen
Antivirals: patients highly susceptible to strong covid:
1)Nirmatrelivir with ritonavir
Nirmatrelvir acts as an orally active 3C like protease inhibitor
2)Remedisivir:
-adenosine analoge
-binds with viral RNA-dependant RNA polymerase and inhibits viral replication
3)molnupiravir:
-inhibitor of RNA dependant RNA polymerase acting like a ribonucleoside analog for RNA polymerase
Drugs For severe hospitalized patients with COVID 19:
-dexamethasone
-remdesivir
-theraputic anticoagualtion
Patients that are in severe need of oxygen receive:
-Dexamethosone
-Baricitinib
-IV tocilizumab
-prophylactic heparin dose
REMDISEVIR NOT GIVEN IN MECHANICAL VENTILATION PATIENTS
Blocker of JAK1 and JAK2:
Baricitinib
anti-IL-6 receptor monoclonal antibody
Tocilizumab